Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

STAAR Surgical Debt to Equity Ratio 2010-2024 | STAA

Current and historical debt to equity ratio values for STAAR Surgical (STAA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. STAAR Surgical debt/equity for the three months ending December 31, 2024 was 0.00.
  
STAAR Surgical Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $0.11B $0.40B 0.28
2024-09-30 $0.11B $0.43B 0.26
2024-06-30 $0.10B $0.41B 0.25
2024-03-31 $0.10B $0.39B 0.25
2023-12-31 $0.10B $0.39B 0.27
2023-09-30 $0.09B $0.38B 0.25
2023-06-30 $0.09B $0.35B 0.25
2023-03-31 $0.08B $0.34B 0.24
2022-12-31 $0.08B $0.34B 0.25
2022-09-30 $0.08B $0.32B 0.23
2022-06-30 $0.08B $0.30B 0.26
2022-03-31 $0.08B $0.28B 0.27
2021-12-31 $0.09B $0.26B 0.34
2021-09-30 $0.08B $0.25B 0.30
2021-06-30 $0.06B $0.24B 0.26
2021-03-31 $0.05B $0.21B 0.24
2020-12-31 $0.06B $0.20B 0.31
2020-09-30 $0.05B $0.19B 0.26
2020-06-30 $0.04B $0.18B 0.25
2020-03-31 $0.04B $0.17B 0.25
2019-12-31 $0.05B $0.16B 0.30
2019-09-30 $0.04B $0.15B 0.29
2019-06-30 $0.04B $0.14B 0.29
2019-03-31 $0.04B $0.14B 0.29
2018-12-31 $0.04B $0.13B 0.26
2018-09-30 $0.03B $0.13B 0.27
2018-06-30 $0.03B $0.05B 0.62
2018-03-31 $0.03B $0.05B 0.71
2017-12-31 $0.03B $0.04B 0.58
2017-09-30 $0.03B $0.04B 0.79
2017-06-30 $0.03B $0.04B 0.66
2017-03-31 $0.03B $0.04B 0.77
2016-12-31 $0.03B $0.04B 0.73
2016-09-30 $0.03B $0.04B 0.76
2016-06-30 $0.03B $0.04B 0.72
2016-03-31 $0.02B $0.04B 0.61
2015-12-31 $0.02B $0.04B 0.62
2015-09-30 $0.02B $0.04B 0.57
2015-06-30 $0.02B $0.04B 0.52
2015-03-31 $0.02B $0.04B 0.56
2014-12-31 $0.02B $0.04B 0.59
2014-09-30 $0.02B $0.04B 0.55
2014-06-30 $0.02B $0.04B 0.54
2014-03-31 $0.02B $0.04B 0.56
2013-12-31 $0.02B $0.04B 0.59
2013-09-30 $0.02B $0.04B 0.57
2013-06-30 $0.02B $0.04B 0.58
2013-03-31 $0.02B $0.03B 0.61
2012-12-31 $0.02B $0.03B 0.73
2012-09-30 $0.02B $0.03B 0.59
2012-06-30 $0.02B $0.03B 0.58
2012-03-31 $0.02B $0.03B 0.58
2011-12-31 $0.02B $0.03B 0.66
2011-09-30 $0.02B $0.03B 0.62
2011-06-30 $0.02B $0.03B 0.67
2011-03-31 $0.02B $0.02B 0.72
2010-12-31 $0.02B $0.02B 0.81
2010-09-30 $0.02B $0.02B 0.78
2010-06-30 $0.02B $0.02B 0.72
2010-03-31 $0.03B $0.02B 1.41
2009-12-31 $0.04B $0.02B 1.79
2009-09-30 $0.04B $0.02B 1.64
2009-06-30 $0.04B $0.02B 1.55
2009-03-31 $0.04B $0.01B 2.46
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.800B $0.314B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47